NCT01912222View on ClinicalTrials.gov

Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Advanced Solid TumorsHematologic Malignancies
Interventions
DRUG

IXAZOMIB

Trial Locations (4)

Unknown

Fairway

Cleveland

Dallas

Houston

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY